anonymous
Guest
anonymous
Guest
Dec 1 (Reuters) - Meda AB
Says divests manufacturing unit Euromed in Spain
* Says total consideration is EUR 82 million in upfront cash for shares of Euromed
* Says unit generates sales of around EUR 40 million and an ebitda margin of around 20 percent on an annual basis
* Says competition filings will be initiated within days and the transaction is expected to complete in Q1 2016 following such clearances Source text for Eikon: Further company coverage: (Stockholm Newsroom)
Says divests manufacturing unit Euromed in Spain
* Says total consideration is EUR 82 million in upfront cash for shares of Euromed
* Says unit generates sales of around EUR 40 million and an ebitda margin of around 20 percent on an annual basis
* Says competition filings will be initiated within days and the transaction is expected to complete in Q1 2016 following such clearances Source text for Eikon: Further company coverage: (Stockholm Newsroom)